HealthcareDrug Manufacturers - GeneralUnited States

GILD.US · Gilead Sciences, Inc.

NMS · US · USD

Latest price130.40美元

30D-10.06%

Vs. base value+173%

Research summary

GILD.US latest organized financial period shows revenue year-over-year comparison is not complete and net income up 1,673% year over year. Current price is about 130.40美元, while the model base case is about 47.75美元; the price is 173% from the base case. This summary is intended for public-information research and model review.

Key financial trend

Unit: 美元

80 records

Revenue-

Net income85.1亿美元

Free cash flow94.56亿美元

Operating cash flow100.2亿美元

Price trend

Price date: 2026/04/23 · Updated: 2026/04/25 07:52

Valuation model range

Hover each model row to inspect formulas and inputs.

Current price130.40美元

Base value47.75美元

Vs. base+173%

Price date2026/04/23

50.13美元47.75美元57.38美元

+173%

Calculated

DCF

Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.

94.78美元88.59美元111.08美元

+47.19%

88.59美元Current price is 47.2% above the base model value.

FormulaValue/share = PV(FCF/share for 10 years) + PV(terminal value)Inputs used

Result: 88.59美元
Current price: 130.40美元
Estimated shares: 1,255,162,242
Discount rate: 9%
Bear value: 94.78美元
Base value: 88.59美元
Bull value: 111.08美元
基准 FCF/股：7.53
基准增长：-2.0%
WACC：9.0%
永续增长：3.0%

Calculated

Owner Earnings

Uses recent net income as an owner-earnings proxy and discounts scenario growth.

50.13美元47.75美元57.38美元

+173%

47.75美元Current price is 173.1% above the base model value.

FormulaValue/share = PV(owner earnings/share) + PV(terminal value)Inputs used

Result: 47.75美元
Current price: 130.40美元
Estimated shares: 1,255,162,242
Discount rate: 9%
Bear value: 50.13美元
Base value: 47.75美元
Bull value: 57.38美元
近 3 年净利润均值近似所有者收益
基准增长：-1.4%
WACC：9.0%

Calculated

Reverse DCF

Solves the forward FCF growth rate implied by the current price.

---

3.1%当前价格隐含未来 FCF 年化增长约 3.1%。

FormulaSolve growth where DCF value/share = current priceInputs used

Result: 3.1%
Current price: 130.40美元
Estimated shares: 1,255,162,242
Discount rate: 9%
基准 FCF/股：7.53
WACC：9.0%
永续增长：3.0%

Calculated

Earnings Power Value

Estimates earnings power value without assuming growth.

44.96美元44.96美元44.96美元

+190%

44.96美元Current price is 190% above the base model value.

FormulaEPV/share = normalized NOPAT / WACC / sharesInputs used

Result: 44.96美元
Current price: 130.40美元
Estimated shares: 1,255,162,242
Discount rate: 9%
Base value: 44.96美元
近 3 年营业利润均值
有效税率按 21% 估算
WACC：9.0%

Updated: 2026/04/25 07:52

Ad placement

Quarterly and annual financial table

Financial DetailsShowing latest 5 / 80

Period	Type	Revenue	Net Income	Free Cash Flow	Diluted EPS
2025/12/30	Annual	-	85.1亿美元	94.56亿美元	6.78
2024/12/30	Annual	-	4.8亿美元	103.1亿美元	0.38
2023/12/30	Annual	-	56.65亿美元	74.21亿美元	4.5
2022/12/30	Annual	-	45.92亿美元	83.44亿美元	3.64
2021/12/30	Annual	-	62.25亿美元	108.1亿美元	4.93

Related stocks

View all

ISRG.USIntuitive Surgical, Inc.US

ALNY.USAlnylam Pharmaceuticals, Inc.US

AMGN.USAmgen Inc.US

DXCM.USDexCom, Inc.US

GEHC.USGE HealthCare Technologies Inc.US

Ad placement